<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Hearts</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Juno</title>
		<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/comment-page-1/#comment-368735</link>
		<dc:creator>Juno</dc:creator>
		<pubDate>Sat, 23 Apr 2011 01:29:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28911#comment-368735</guid>
		<description>Any updates on how this and other stem cell companies do these days given the current crisis of US economy, consequent reduction of funding from NIH and private sector and yet, more exciting developments in the stem cell field?</description>
		<content:encoded><![CDATA[<p>Any updates on how this and other stem cell companies do these days given the current crisis of US economy, consequent reduction of funding from NIH and private sector and yet, more exciting developments in the stem cell field?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Hearts &#171; Stem Cell News</title>
		<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/comment-page-1/#comment-67044</link>
		<dc:creator>UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Hearts &#171; Stem Cell News</dc:creator>
		<pubDate>Mon, 22 Jun 2009 05:11:34 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28911#comment-67044</guid>
		<description>[...] Read more on xconomy [...]</description>
		<content:encoded><![CDATA[<p>[...] Read more on xconomy [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Luke Timmerman</title>
		<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/comment-page-1/#comment-65459</link>
		<dc:creator>Luke Timmerman</dc:creator>
		<pubDate>Sat, 13 Jun 2009 18:07:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28911#comment-65459</guid>
		<description>Here&#039;s Buddy Ratner&#039;s response to the question about the $20 million in NIH support:

&quot;The $20M number is real. It was a grant at $2 million per year for 10 years in the NIH Bioengineering Research Partnership (BRP) program to Professors Ratner and Murry at the University of Washington (the grant is in its last year).

Interestingly, the grant started under the G. W. Bush administration. Thus we were limited to approved lines of human embryonic stem cells. Even with this limitation (that we no longer have), we were able to show proof of principle. Of course, the grant was much larger in scope than just stem cells for heart muscle repair -- it addressed cell sources, heart mechanics, electrical properties, biomaterials, surgery and other issues.&quot;</description>
		<content:encoded><![CDATA[<p>Here’s Buddy Ratner’s response to the question about the $20 million in NIH support:</p>
<p>“The $20M number is real. It was a grant at $2 million per year for 10 years in the NIH Bioengineering Research Partnership (BRP) program to Professors Ratner and Murry at the University of Washington (the grant is in its last year).</p>
<p>Interestingly, the grant started under the G. W. Bush administration. Thus we were limited to approved lines of human embryonic stem cells. Even with this limitation (that we no longer have), we were able to show proof of principle. Of course, the grant was much larger in scope than just stem cells for heart muscle repair — it addressed cell sources, heart mechanics, electrical properties, biomaterials, surgery and other issues.”</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: chloe</title>
		<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/comment-page-1/#comment-65109</link>
		<dc:creator>chloe</dc:creator>
		<pubDate>Fri, 12 Jun 2009 14:54:58 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28911#comment-65109</guid>
		<description>i read your article on Beat Biotherapeutics.  i had to question the NIH funding amount of 20 Million.  that is an extreamly large amount of funding considering that grants usually are under 500k. Is the 20million number accurate?  can it be varified?  i ask because there are many stem cell companies that are underfunded and i have yet to see participation from the NIH at this level before.  is this a leading indication of how the Obama administration is going to support stem cell research. if the 20 million figure checks out then i think there is a larger story here. thanks, tony</description>
		<content:encoded><![CDATA[<p>i read your article on Beat Biotherapeutics.  i had to question the NIH funding amount of 20 Million.  that is an extreamly large amount of funding considering that grants usually are under 500k. Is the 20million number accurate?  can it be varified?  i ask because there are many stem cell companies that are underfunded and i have yet to see participation from the NIH at this level before.  is this a leading indication of how the Obama administration is going to support stem cell research. if the 20 million figure checks out then i think there is a larger story here. thanks, tony</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Could health information technology be the root of reform? &#8212; MedCity Morning Read, June 11, 2009 : MedCity News</title>
		<link>http://www.xconomy.com/seattle/2009/06/11/uw-spinout-beat-biotherapeutics-aims-to-make-stem-cells-for-damaged-hearts/comment-page-1/#comment-64691</link>
		<dc:creator>Could health information technology be the root of reform? &#8212; MedCity Morning Read, June 11, 2009 : MedCity News</dc:creator>
		<pubDate>Thu, 11 Jun 2009 11:31:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28911#comment-64691</guid>
		<description>[...] UW spinout, Beat BioTherapeutics, aims to make stem cells for damaged hearts (Xconomy &#124; Seattle) [...]</description>
		<content:encoded><![CDATA[<p>[...] UW spinout, Beat BioTherapeutics, aims to make stem cells for damaged hearts (Xconomy | Seattle) [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

